Literature DB >> 19118222

Safety of long-acting beta-agonists: urgent need to clear the air remains.

R Beasley, F D Martinez, A Hackshaw, K F Rabe, P J Sterk, R Djukanovic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19118222      PMCID: PMC4852141          DOI: 10.1183/09031936.00163408

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  23 in total

1.  Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid- and salmeterol-containing products.

Authors:  Rachael L DiSantostefano; Kourtney J Davis; Steve Yancey; Courtney Crim
Journal:  Ann Allergy Asthma Immunol       Date:  2008-06       Impact factor: 6.347

2.  The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

Authors:  Harold S Nelson; Scott T Weiss; Eugene R Bleecker; Steven W Yancey; Paul M Dorinsky
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 3.  Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma.

Authors:  C G Löfdahl; K F Chung
Journal:  Eur Respir J       Date:  1991-02       Impact factor: 16.671

Review 4.  Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Authors:  M Ni Chroinin; I R Greenstone; A Danish; H Magdolinos; V Masse; X Zhang; F M Ducharme
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

5.  Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.

Authors:  A Grove; B J Lipworth
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

6.  Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma.

Authors:  J Crane; N Pearce; C Burgess; K Woodman; B Robson; R Beasley
Journal:  Int J Epidemiol       Date:  1992-08       Impact factor: 7.196

7.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

8.  Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials.

Authors:  M R Sears; A Ottosson; F Radner; S Suissa
Journal:  Eur Respir J       Date:  2008-09-03       Impact factor: 16.671

9.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Authors:  W Castle; R Fuller; J Hall; J Palmer
Journal:  BMJ       Date:  1993-04-17

10.  Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma.

Authors:  D M Newnham; D G McDevitt; B J Lipworth
Journal:  Am J Med       Date:  1994-07       Impact factor: 4.965

View more
  5 in total

1.  Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies.

Authors:  Shoroq M Altawalbeh; Carolyn T Thorpe; Janice C Zgibor; Sandra Kane-Gill; Yihuang Kang; Joshua M Thorpe
Journal:  J Am Geriatr Soc       Date:  2016-06-28       Impact factor: 5.562

2.  Salmeterol use and risk of hospitalization among emergency department patients with acute asthma.

Authors:  Michael M Liao; Adit A Ginde; Sunday Clark; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2010-06       Impact factor: 6.347

3.  Regional variation and adherence to guidelines for drug treatment of asthma.

Authors:  Marianne Heibert Arnlind; Björn Wettermark; Mika Nokela; Paul Hjemdahl; Clas Rehnberg; Eva Wikström Jonsson
Journal:  Eur J Clin Pharmacol       Date:  2009-10-14       Impact factor: 2.953

4.  The role of tiotropium in the management of asthma.

Authors:  Heung-Woo Park
Journal:  Asia Pac Allergy       Date:  2012-04-30

Review 5.  The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Authors:  Marc L Decramer; Nicola A Hanania; Jan O Lötvall; Barbara P Yawn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.